Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differently Selected <scp>d</scp> -Enantiomeric Peptides Act on Different Aβ Species

2 Dec 2009

Abstract excerpt

Aging is the most significant risk factor for Alzheimer disease (AD). The pathological hallmark of AD is the accumulation of aggregated amyloid-beta (Abeta) forms and insoluble plaques, mainly composed of Abeta, in the brain of the patient. Recently, we reported on the selection of D-enantiomeric, Abeta-binding peptides D1 and D3. D1 was selected against aggregated Abeta species to address diagnosis by in vivo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amino Acid Enzymes and Metabolism

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19954333
DOI: 10.1089/rej.2009.0924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differently Selected <scp>d</scp> -Enantiomeric Peptides Act on Different Aβ SpeciesPMID 19954333Read ↗

Reduction of Alzheimer’s Disease Amyloid Plaque Load in Transgenic Mice by D3, a <scp>D</scp> ‐Enantiomeric Peptide Identified by Mirror Image Phage DisplaySemantic proximity Read ↗

Oral Treatment with the <scp>d</scp>-Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer’s Disease Transgenic MiceSemantic proximity Read ↗

Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.Semantic proximity Read ↗

In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42‐Binding <scp>D</scp>‐Enantiomeric Peptides in Transgenic AD Mouse ModelsSemantic proximity Read ↗

Direct disassembly of α-syn preformed fibrils into native α-syn monomers by an all-D-peptideSemantic proximity Read ↗

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

Aβ oligomer eliminating compounds interfere successfully with pEAβ(3-42) induced motor neurodegenerative phenotype in transgenic mice.Semantic proximity Read ↗

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitroSemantic proximity Read ↗

Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice.Semantic proximity Read ↗

Aptamers Selected for Recognizing Amyloid β-protein—A Case for Cautious OptimismSemantic proximity Read ↗

Solid-state NMR sequential assignment of Osaka-mutant amyloid-beta (Aβ1-40 E22Δ) fibrils.Semantic proximity Read ↗

Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.